Related Experiment Videos
Nitric oxide decreases coagulation protein function in rabbits as assessed by thromboelastography
1Department of Anesthesiology, Division of Cardiothoracic Anesthesia, The University of Alabama at Birmingham, Birmingham, Alabama 35249, USA. vance.nielsen@ccc.uab.edu
Anesthesia and Analgesia
|February 13, 2001
Summary
Nitric oxide (NO) donors like DETANONOate impair blood clotting by reducing coagulation protein and platelet function. This finding is crucial for understanding NO donor effects in clinical settings.
Area of Science:
- Biochemistry
- Hematology
- Pharmacology
Background:
- Nitric oxide (NO) administration is used clinically for conditions like pulmonary hypertension.
- NO donors, such as nitroglycerin and DETANONOate, are employed in various medical treatments.
- The impact of NO on blood coagulation, particularly protein and platelet function, requires further investigation.
Purpose of the Study:
- To investigate the hypothesis that DETANONOate-derived NO adversely affects coagulation protein and platelet function.
- To quantify the effects of DETANONOate on thromboelastographic variables and platelet contribution to clot strength.
Main Methods:
- Blood from conscious rabbits was collected and anticoagulated with sodium citrate.
- Samples were incubated with 0 or 10mM DETANONOate for 30 minutes.
- Thromboelastography was performed under four conditions: control, platelet inhibition, DETANONOate exposure, and DETANONOate with platelet inhibition.
Main Results:
- DETANONOate significantly increased reaction time (R) and decreased clot angle (alpha) and clot strength (G) (P < 0.05).
- These effects were observed both with and without platelet inhibition, indicating an impact on coagulation proteins.
- The percentage of clot strength attributable to platelets (G(P)) was significantly reduced after DETANONOate exposure.
Conclusions:
- DETANONOate-derived NO significantly impairs both coagulation protein and platelet function.
- Clinical administration of NO or NO donors may similarly affect coagulation in patients.
- Further research is warranted to elucidate the precise mechanisms and clinical implications.